There’s gold in them thar hills

|

Published 22-JUL-2019 11:27 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

There’s gold in them thar hills.

It’s a favourite expression of mine. Made famous by Yosemite Sam in the Looney Tunes cartoons.

Yosemite's gold prospecting attempts were constantly thwarted by Bugs Bunny, because let’s face it, nobody ever got the better of Bugs.

However, if Yosemite was referring to gold mines in Georgia or California in the 1800s, he would have been right on the money and his battle with Bugs more severe.

How did Bugs Bunny always get the better of Yosemite Sam?

The phrase ‘There’s gold in them thar hills’ is, in fact, a misquote. The actual phrase was yelled from the steps of the Lumpkin County Courthouse in 1849 by Dahlonega Mint assayor Dr. M. F. Stephenson to stop the exodus of miners from Dahlonega in Georgia to California, which had just started its own gold rush.

Fast forward 120-odd years later and it looks as if we could be in a gold rush all over again.

Forbes suggests the gold price is likely to appreciate by 7.95% in the very near term. Gold is currently sitting at $1440 per ounce, a long way back from the all-time high of $1921 in September 2011, but Forbes author Nassem Aslam is predicting it to hit $1550.

Even more bullish is billionaire Ray Dalio. The founder of investment management firm Bridgewater Associates said in a long-form LinkedIn piece: "I believe that it would be both risk-reducing and return-enhancing to consider adding gold to one's portfolio."

Dalio went on to state: "The big question worth pondering at this time is which investments will perform well in a reflationary environment accompanied by large liabilities coming due and with significant internal conflict between capitalists and socialists, as well as external conflicts."

Lots to ponder.

There’s certainly gold in the hills based on the current gold price and the macro events that are affecting it.

In the last 48 hours, the US dollar dropped to its lowest level in a month, whilst gold spot prices surged to a six year high.

The Fed Reserve rate cuts speculation is also having an impact.

On the back of all of this, silver is also performing well.

Kitco Metals global trading director Peter Hug said, “I think people are starting to catch on to the fact that this market is overall in a bullish trend, which I do believe it is, that silver is extremely undervalued compared to gold, and that now we’re starting to see some retail demand coming into the silver market.”

Here’s Hug talking about the gold silver dynamic.

The rise in silver price could work in favour for stocks such as Pacifico Minerals and its Sorby Hills Lead Silver Zinc Project and Inca which recently identified bonanza grade silver at its Riqueza Project.

ASX stocks which could benefit from the current gold price can be found in this comprehensive guide to gold stocks: Thirty solid gold stocks to whet your appetite.

Kingston is another: Kingston delivers promising news at Quartz Mountain and IDA, could also come out on top given current circumstances: Impressive Indiana results consistent with highly prospective area.

If gold does continue to rise, there would certainly be many stocks, ASX and otherwise that should do well.

Investors in gold and silver too, so it’s worth keeping an eye on gold in the foreseeable future.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X